Parameter | Patient Value | Reference |
---|---|---|
ADAMTS13 | ||
ADAMTS-13-antibodies (U/mL) | 1.8 | < 12 |
ADAMTS-13-activity (IU/mL) | 1.09 | 0.4–1.3 |
ADAMTS-13-antigen (IU/mL) | 0.38 | 0.41–1.41 |
Complement | ||
Complement classical pathway (%) | 0,79 | 74–151 |
Complement alternative pathway (%) | 1,11 | 60–140 |
Complement C3 (mU/L) | 16 | < 40 |
sC5b-9 terminal Membrane attack complex (ng/mL) | 184 | 58–239 |
Hematology | ||
Hemoglobin (g/dl) | 11.3 | 11,8-15,5 |
Platetlet count (× 103/μl) | 290 | 160–400 |
White blood cell count (/μL) | 6.92 × 103 | 4–11 |
Schistocyte-Count | < 0.1 | |
Blood chemistry | ||
Lactate dehydrogenase (U/L) | 565 | < 250 |
Haptoglobin (mg/L) | 309 | 300–2000 |
C-reactive protein (mg/L) | 16.5 | < 5 |
Total serum bilirubin (mg/dl) | 0.4 | < 1.1 |